Clinical Trial Update: Long-term Follow-up of Gene Therapy for Radiation-Induced Xerostomia [Phase 2]

View source ↗

Summary

An update on long-term follow-up for a Phase 2 gene therapy targeting radiation-induced xerostomia in patients treated for upper aerodigestive tract cancers; en…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Xerostomia

Drugs mentioned

• MeiraGTx gene therapy

Snippet

Sponsor: MeiraGTx, LLC | Conditions: Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands | Phase 2 | Status: ENROLLING_BY_INVITATION